Current Colorectal Cancer Reports

, Volume 9, Issue 2, pp 203–212

Management of the Hepatic Lymph Nodes During Resection of Liver Metastases from Colorectal Cancer: A Systematic Review

  • Rahul S. Koti
  • Constantinos Simillis
  • Kurinchi S. Gurusamy
  • Michael Jacovides
  • Brian R. Davidson
Colorectal Cancer Hepatic Metastases (KK Tanabe, Section Editor)

Abstract

The aim of this review is to assess the role of hepatic lymphadenectomy in patients undergoing liver resection for colorectal metastases. Meta-analysis of trials identified by a systematic literature search of the Medline, Embase and Central databases was performed. There were no randomized controlled trials which assessed the survival benefit to patients undergoing liver resection for colorectal metastases of either a routine or a ‘selective’ lymphadenectomy. The prevalence of nodal metastases after lymphadenectomy was 8.4 %. The overall 3-year and 5-year survival rates in patients with hepatic lymph node metastases undergoing hepatectomy were 21.8 % (63 of 288 patients) and 8.5 % (27 of 315 patients), respectively, compared with 58.2 % (1,366 of 2,346 patients) and 47.5 % (1,717 of 3,609 patients) in patients undergoing hepatectomy who had no hepatic nodal metastases. The odds ratios for 3-year and 5-year mortality in node positive disease compared with node negative disease were 4.54 (95 % confidence interval 3.15–6.54) and 6.33 (95 % confidence interval 4.28–9.36), respectively. In conclusion, long-term survival rates are low in patients undergoing hepatectomy with hepatic lymph node metastases. The poor outcome is irrespective of whether the nodal metastases are discovered following routine lymphadenectomy or are detected because of pathological enlargement. Further trials in this patient group are required.

Keywords

Liver Colorectal cancer Metastases Resection Hepatic Lymph nodes Hilar Portal Para-aortic Coeliac Survival Surgery Chemotherapy Systematic review Meta-analysis 

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. 1.
    Rodgers MS, McCall JL. Surgery for colorectal liver metastases with hepatic lymph node involvement: a systematic review. Br J Surg. 2000;87(9):1142–55.PubMedCrossRefGoogle Scholar
  2. 2.
    Poston GJ, Adam R, Alberts S, et al. OncoSurge: a strategy for improving resectability with curative intent in metastatic colorectal cancer. J Clin Oncol. 2005;23(28):7125–34.PubMedCrossRefGoogle Scholar
  3. 3.
    Jaeck D, Nakano H, Bachellier P, et al. Significance of hepatic pedicle lymph node involvement in patients with colorectal liver metastases: a prospective study. Ann Surg Oncol. 2002;9(5):430–8.PubMedCrossRefGoogle Scholar
  4. 4.
    Beckurts KT, Holscher AH, Thorban S, et al. Significance of lymph node involvement at the hepatic hilum in the resection of colorectal liver metastases. Br J Surg. 1997;84(8):1081–4.PubMedCrossRefGoogle Scholar
  5. 5.
    Laurent C, Sa Cunha A, Rullier E, et al. Impact of microscopic hepatic lymph node involvement on survival after resection of colorectal liver metastasis. J Am Coll Surg. 2004;198(6):884–91.PubMedCrossRefGoogle Scholar
  6. 6.
    • Alberts SR, Wagman LD. Chemotherapy for colorectal cancer liver metastases. Oncologist. 2008;13(10):1063–73. The authors reviewed past and present chemotherapy regimens for metastatic colorectal cancer.PubMedCrossRefGoogle Scholar
  7. 7.
    • Adam R, de Haas RJ, Wicherts DA, et al. Is hepatic resection justified after chemotherapy in patients with colorectal liver metastases and lymph node involvement? J Clin Oncol. 2008;26(22):3672–80. The authors demonstrated 5-year survival in a highly selected group of patients.PubMedCrossRefGoogle Scholar
  8. 8.
    • Pulitanò C, Bodingbauer M, Aldrighetti L, et al. Liver resection for colorectal metastases in presence of extrahepatic disease: results from an international multi-institutional analysis. Ann Surg Oncol. 2011;18(5):1380–8. This is a report of a relatively large series where the authors reviewed their data on nodal involvement in metastatic colorectal cancer patients.PubMedCrossRefGoogle Scholar
  9. 9.
    • Carpizo DR, Are C, Jarnagin W, et al. Liver resection for metastatic colorectal cancer in patients with concurrent extrahepatic disease: results in 127 patients treated at a single center. Ann Surg Oncol. 2009;16(8):2138–46. This is a report of a relatively large series where the authors reviewed their data on concurrent extrahepatic disease in metastatic colorectal cancer patients.PubMedCrossRefGoogle Scholar
  10. 10.
    Lupinacci RM, Coelho FF, Kruger J, et al. Hilar lymph node involvement in colorectal cancer liver metastases – an overview. J Gastrointest Digest Sys. 2011;S6:002. doi:10.4172/jgds.S6-002.Google Scholar
  11. 11.
    Bennett JJ, Schmidt CR, Klimstra DS, et al. Perihepatic lymph node micrometastases impact outcome after partial hepatectomy for colorectal metastases. Ann Surg Oncol. 2008;15(4):1130–6.PubMedCrossRefGoogle Scholar
  12. 12.
    Gurusamy KS, Imber C, Davidson BR. Management of the hepatic lymph nodes during resection of liver metastases from colorectal cancer: a systematic review. HPB Surg. 2008;2008:684150. doi:10.1155/2008/684150.PubMedCrossRefGoogle Scholar
  13. 13.
    Review Manager version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration; 2011.Google Scholar
  14. 14.
    Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med. 1998;17(24):2815–34.PubMedCrossRefGoogle Scholar
  15. 15.
    DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–88.PubMedCrossRefGoogle Scholar
  16. 16.
    Demets DL. Methods for combining randomized clinical trials: strengths andlimitations. Stat Med. 1987;6(3):341–50.PubMedCrossRefGoogle Scholar
  17. 17.
    Ambiru S, Miyazaki M, Isono T, et al. Hepatic resection for colorectal metastases: analysis of prognostic factors. Dis Colon Rectum. 1999;42(5):632–9.PubMedCrossRefGoogle Scholar
  18. 18.
    Kokudo N, Seki M, Ohta H, et al. Effects of systemic and regional chemotherapy after hepatic resection for colorectal metastases. Ann Surg Oncol. 1998;5(8):706–12.PubMedCrossRefGoogle Scholar
  19. 19.
    Nakamura S, Yokoi Y, Suzuki S, et al. Results of extensive surgery for liver metastases in colorectal carcinoma. Br J Surg. 1992;79(1):35–8.PubMedCrossRefGoogle Scholar
  20. 20.
    Rosen CB, Nagorney DM, Taswell HF, et al. Perioperative blood transfusion and determinants of survival after liver resection for metastatic colorectal carcinoma. Ann Surg. 1992;216(4):493–504.PubMedCrossRefGoogle Scholar
  21. 21.
    Harms J, Obst T, Thorban S, et al. The role of surgery in the treatment of liver metastases for colorectal cancer patients. Hepatogastroenterology. 1999;46(28):2321–8.PubMedGoogle Scholar
  22. 22.
    Yasui K, Hirai T, Kato T, et al. Major anatomical hepatic resection with regional lymph node dissection for liver metastases from colorectal cancer. J Hepatobiliary Pancreat Surg. 1995;2:103–7.CrossRefGoogle Scholar
  23. 23.
    Sanchez-Cespedes M, Esteller M, Hibi K, et al. Molecular detection of neoplastic cells in lymph nodes of metastatic colorectal cancer patients predicts recurrence. Clin Cancer Res. 1999;5(9):2450–4.PubMedGoogle Scholar
  24. 24.
    Minagawa M, Makuuchi M, Torzilli G, et al. Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer- long term results. Ann Surg. 2000;231(4):487–99.PubMedCrossRefGoogle Scholar
  25. 25.
    Aoki T, Umekita N, Tanaka S, et al. Prognostic value of concomitant resection of extrahepatic disease in patients with liver metastases of colorectal origin. 2008;143(6):706–14.Google Scholar
  26. 26.
    Oussoultzoglou E, Rosso E, Fuchshuber P, et al. Perioperative carcinoembryonic antigen measurements to predict curability after liver resection for colorectal metastases. Arch Surg. 2008;143(12):1150–8.PubMedCrossRefGoogle Scholar
  27. 27.
    Jonas S, Thelen A, Benckert C, et al. Extended resections of liver metastases from colorectal cancer. World J Surg. 2007;31(3):511–21.PubMedCrossRefGoogle Scholar
  28. 28.
    Settmacher U, Dittmar Y, Knösel T, et al. Predictors of long-term survival in patients with colorectal liver metastases: a single center study and review of the literature. Int J Color Dis. 2011;26(8):967–81.CrossRefGoogle Scholar
  29. 29.
    Ishida H, Ishibashi K, Ohsawa T, et al. Significance of hepatic lymph node metastasis in patients with unresectable synchronous liver metastasis of colorectal cancer. Int Surg. 2011;96(4):291–9.PubMedCrossRefGoogle Scholar
  30. 30.
    Lupinacci RM, Herman P, Coelho FC, et al. Diagnosis and impact of hilar lymph node micrometastases on the outcome of resected colorectal liver metastasis. Hepatogastroenterology. 2013.Google Scholar
  31. 31.
    Grobmyer SR, Wang L, Gonen M, et al. Perihepatic lymph node assessment in patients undergoing partial hepatectomy for malignancy. Ann Surg. 2006;244(2):260–4.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Rahul S. Koti
    • 1
  • Constantinos Simillis
    • 1
  • Kurinchi S. Gurusamy
    • 1
  • Michael Jacovides
    • 1
  • Brian R. Davidson
    • 1
  1. 1.University Department of SurgeryRoyal Free Campus, UCL Medical SchoolLondonUK

Personalised recommendations